NO971376L - N-substituerte piperidinyl bisykliske benzoatderivater - Google Patents

N-substituerte piperidinyl bisykliske benzoatderivater

Info

Publication number
NO971376L
NO971376L NO971376A NO971376A NO971376L NO 971376 L NO971376 L NO 971376L NO 971376 A NO971376 A NO 971376A NO 971376 A NO971376 A NO 971376A NO 971376 L NO971376 L NO 971376L
Authority
NO
Norway
Prior art keywords
6alkyl
substituted
halo
hydrogen
alk
Prior art date
Application number
NO971376A
Other languages
English (en)
Other versions
NO971376D0 (no
NO313238B1 (no
Inventor
Georges Henri Paul Van Daele
Jean-Paul Rene Marie A Bosmans
Frans Maria Alfons Van Keybus
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO971376D0 publication Critical patent/NO971376D0/no
Publication of NO971376L publication Critical patent/NO971376L/no
Publication of NO313238B1 publication Critical patent/NO313238B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19971376A 1994-09-27 1997-03-24 N-substituerte piperidinyl bisykliske benzoatderivater NO313238B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP94202792 1994-09-27
US45548695A 1995-05-31 1995-05-31
PCT/EP1995/003691 WO1996010027A1 (en) 1994-09-27 1995-09-19 N-substituted piperidinyl bicyclic benzoate derivatives

Publications (3)

Publication Number Publication Date
NO971376D0 NO971376D0 (no) 1997-03-24
NO971376L true NO971376L (no) 1997-05-05
NO313238B1 NO313238B1 (no) 2002-09-02

Family

ID=26136613

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19971376A NO313238B1 (no) 1994-09-27 1997-03-24 N-substituerte piperidinyl bisykliske benzoatderivater

Country Status (23)

Country Link
EP (1) EP0784620B1 (no)
JP (1) JP3953097B2 (no)
CN (1) CN1068880C (no)
AT (1) ATE187453T1 (no)
AU (1) AU699152B2 (no)
BR (1) BR9509036A (no)
CA (1) CA2200578C (no)
CZ (1) CZ289031B6 (no)
DE (1) DE69513846T2 (no)
DK (1) DK0784620T3 (no)
ES (1) ES2141383T3 (no)
FI (1) FI119640B (no)
GR (1) GR3032646T3 (no)
HU (1) HU218698B (no)
IL (1) IL115413A (no)
MY (1) MY113202A (no)
NO (1) NO313238B1 (no)
NZ (1) NZ293605A (no)
PL (1) PL182502B1 (no)
PT (1) PT784620E (no)
RU (1) RU2154064C2 (no)
WO (1) WO1996010027A1 (no)
ZA (1) ZA958081B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1077973A2 (en) * 1998-05-14 2001-02-28 Egis Gyogyszergyar Rt. Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient
PL214274B1 (pl) 2002-01-16 2013-07-31 Movetis N V N-Tlenek prukaloprydu, sposób jego wytwarzania i zastosowanie oraz zawierająca go kompozycja i sposób jej wytwarzania
US7834010B2 (en) 2003-12-23 2010-11-16 Serodus As Modulators of peripheral 5-HT receptors
EP1758580A4 (en) 2004-06-24 2008-01-16 Incyte Corp N-SUBSTITUTED PIPERIDINE AND ITS USE AS A MEDICAMENT
EP1945632B1 (en) 2005-11-08 2013-09-18 Vertex Pharmaceuticals Incorporated Heterocyclic modulators of atp-binding cassette transporters
EP2789606B1 (en) 2007-05-09 2017-11-15 Vertex Pharmaceuticals Incorporated Modulators of CFTR
NZ612635A (en) 2007-12-07 2015-06-26 Vertex Pharma Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
EP3683218B1 (en) 2007-12-07 2024-09-18 Vertex Pharmaceuticals Incorporated Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
CA2931134C (en) 2008-02-28 2019-07-30 Vertex Pharmaceuticals Incorporated Heteroaryl derivatives as cftr modulators
HRP20211752T1 (hr) 2010-04-07 2022-02-18 Vertex Pharmaceuticals Incorporated Farmaceutski pripravci 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioksol-5-il)ciklopropankarboksamido)-3-metilpiridin-2-il)benzojeve kiseline i njihova primjena
MX2012011655A (es) * 2010-04-07 2012-11-23 Vertex Pharma Formas solidas de acido 3-(6-(1-(2,2-difluorobenzo [d][1-3]dioxol-5-il]ciclopropanocarboxamido)-3-metilpiridin-2-il) benzoico.
US10231932B2 (en) 2013-11-12 2019-03-19 Vertex Pharmaceuticals Incorporated Process of preparing pharmaceutical compositions for the treatment of CFTR mediated diseases
SG11201703963QA (en) 2014-11-18 2017-06-29 Vertex Pharma Process of conducting high throughput testing high performance liquid chromatography

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1317940C (en) * 1987-09-25 1993-05-18 Georges H. P. Van Daele Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
DE3810552A1 (de) * 1988-03-29 1989-10-19 Sandoz Ag Ester und amide von indol-, benzo(b)thiopen-, benzo(b)furancarbonsaeuren oder 4-amino-2-methoxy-benzolsaeuren mit n-heterocyclischen oder n-heterobicyclischen alkoholen oder aminen, verfahren zu deren herstellung sie enthaltende pharmazeutische zusammensetzungen sowie applikator zur verabreichung derselben
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
NZ243993A (en) * 1991-08-20 1994-10-26 Smithkline Beecham Plc Pharmaceutical compositions having 5-ht4 receptor antagonist activity and selected compounds having such activity
MX9306311A (es) * 1992-10-13 1994-04-29 Smithkline Beecham Plc Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen

Also Published As

Publication number Publication date
CN1166171A (zh) 1997-11-26
PL319997A1 (en) 1997-09-01
NZ293605A (en) 1998-07-28
DK0784620T3 (da) 2000-05-22
CZ91897A3 (en) 1997-12-17
ES2141383T3 (es) 2000-03-16
AU699152B2 (en) 1998-11-26
MX9702363A (es) 1997-10-31
EP0784620B1 (en) 1999-12-08
EP0784620A1 (en) 1997-07-23
JPH10506118A (ja) 1998-06-16
PT784620E (pt) 2000-05-31
FI971274A (fi) 1997-03-26
IL115413A (en) 2000-02-17
NO971376D0 (no) 1997-03-24
FI119640B (fi) 2009-01-30
WO1996010027A1 (en) 1996-04-04
RU2154064C2 (ru) 2000-08-10
CN1068880C (zh) 2001-07-25
CZ289031B6 (cs) 2001-10-17
MY113202A (en) 2001-12-31
DE69513846D1 (de) 2000-01-13
GR3032646T3 (en) 2000-06-30
ZA958081B (en) 1997-03-26
DE69513846T2 (de) 2000-07-06
HU218698B (hu) 2000-11-28
JP3953097B2 (ja) 2007-08-01
AU3608195A (en) 1996-04-19
PL182502B1 (pl) 2002-01-31
CA2200578A1 (en) 1996-04-04
BR9509036A (pt) 1997-10-14
NO313238B1 (no) 2002-09-02
HUT77173A (hu) 1998-03-02
IL115413A0 (en) 1995-12-31
CA2200578C (en) 2006-11-07
ATE187453T1 (de) 1999-12-15
FI971274A0 (fi) 1997-03-26

Similar Documents

Publication Publication Date Title
NO971376L (no) N-substituerte piperidinyl bisykliske benzoatderivater
TW369526B (en) Diazabicyclic neurokinin antagonists
DE60040901D1 (de) Polyhydroxyalkanoat
BG93979A (bg) Производни на n-(4-пиперидинил)(дихидробензофуран или дихидро-2н-бензопиран)карбоксамид, фармацевтичен състав, който ги съдържа, метод за получаване на производните и приложението им
CA2036876A1 (fr) Derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MY101359A (en) 7-acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them, their starting compounds and their preparation
DK0479546T3 (da) Piperazinderivater
ATE171943T1 (de) Piperidin-verbindungen, ihre darstellung und ihre verwendung
BG104717A (en) Water soluble azoles as broad-spectrum antifungals
PL322872A1 (en) Novel triazolones - inhibitors of b apolipoprotein synthesis
HUP9801751A2 (hu) Benzopiránszármazékok, azok előállítása és alkalmazása, valamint ilyen származékokat tartalmazó gyógyszerkészítmények
TW360653B (en) A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition
AP1396A (en) 1-Trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives.
DK1150974T3 (da) Heterocykliske derivater som inhibitor af faktor Xa
ATE178064T1 (de) Phenyl-oxo-alkyl-(4-piperidinyl) benzoatderivate
JO1648B1 (en) Nitrogen compounds
JO1697B1 (en) Pyridine derivatives

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees